Living better or living longer? Perceptions of patients and health care professionals in oncology
Carregando...
Citações na Scopus
3
Tipo de produção
article
Data de publicação
2015
Título da Revista
ISSN da Revista
Título do Volume
Editora
CANCER INTELLIGENCE LTD
Autores
CRITCHI, Gabriela
MANGABEIRA, Andrea
SAAD, Everardo D.
Citação
ECANCERMEDICALSCIENCE, v.9, article ID 574, 8p, 2015
Resumo
Background: Cancer can influence the views of patients on treatment goals and make them different from those of health care professionals (HCPs). It is crucial to understand patient expectations regarding cancer treatment. Methods: We performed a cross-sectional survey of patients with cancer and HCPs to evaluate their perceptions about treatment priorities and to analyse variables that might influence their opinions. To identify treatment choices, we interviewed all participants using a structured questionnaire with fictitious case vignettes. Results: We enrolled a total of 230 participants, including 144 patients and 86 HCPs (35 nurses, 21 physicians, 30 others). Treatment priority between survival time (28.5% for patients vs. 8.1% for HCP) and quality of life (45.8% vs. 87.2%) differed significantly, with the remaining participants stating they were uncertain or unwilling to respond, or providing invalid responses (P < 0.01). In logistic regression, prioritising survival time was more frequent in patients, adjusting for age and gender (odds ratio (OR) = 3.95; P < 0.01). The view that the physician alone should be responsible for treatment choices was more frequent among patients than HCPs (18.8 vs. 5.8%; P = 0.01). Conclusions: In Brazil, our results suggest that survival time is more important for patients with cancer than for HCPs, whereas quality of life is more important for HCPs than for patients with cancer, who place great emphasis on physicians as decision-makers. Given that Brazilian patients often rely on physicians for decisions, the potential impact of different priorities between survival time and quality of life when patients and HCPs are compared is unknown.
Palavras-chave
cancer, overall survival, quality of life, treatment
Referências
- de Bekker-Grob EW, 2013, BRIT J CANCER, V109, P633, DOI 10.1038/bjc.2013.370
- Matsuyama R, 2006, J CLIN ONCOL, V24, P3490, DOI 10.1200/JCO.2005.03.6236
- Crawford ED, 1997, UROLOGY, V50, P366
- BLACKHALL LJ, 1995, JAMA-J AM MED ASSOC, V274, P820, DOI 10.1001/jama.274.10.820
- Scher HI, 2011, J CLIN ONCOL, V29, P3695, DOI 10.1200/JCO.2011.35.8648
- Weeks JC, 1998, JAMA-J AM MED ASSOC, V279, P1709, DOI 10.1001/jama.279.21.1709
- Hagerty RG, 2005, ANN ONCOL, V16, P1005, DOI 10.1093/annonc/mdi211
- Balmer CE, 2001, PSYCHO-ONCOL, V10, P410, DOI 10.1002/pon.538
- Hirose T, 2005, INTERNAL MED, V44, P107, DOI 10.2169/internalmedicine.44.107
- Motlagh A, 2014, ARCH IRAN MED, V17, P232, DOI 014174/AIM.004
- Marta GN, 2014, CLINICS, V69, P509, DOI 10.6061/clinics/2014(08)02
- Booth CM, 2008, J CLIN ONCOL, V26, P6, DOI 10.1200/JCO.2007.13.8156
- Chin J. J., 2002, SMJ Singapore Medical Journal, V43, P152
- Da Codta Di Bonaventura M, 2014, AM HLTH DRUG BENEFIT, V7, P386
- SLEVIN ML, 1990, BRIT MED J, V300, P1458